The clinical and economic impact of pharmaceutical care in end-stage renal disease patients

Seminars in Dialysis

Volumn 15, Issue 1, 2002, Pages 45-49

  Manley, Harold J ^a   Carroll, Cathryn A ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; COST BENEFIT ANALYSIS; DRUG THERAPY; ECONOMICS; HEALTH CARE COST; HOME CARE; HOSPITALIZATION; HUMAN; KIDNEY TRANSPLANTATION; REVIEW; STATISTICS;

COST-BENEFIT ANALYSIS; DRUG THERAPY; HEALTH CARE COSTS; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION;

EID: 0036365861     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139x.2002.00014.x     Document Type: Review

References (26)

1. U.S. Renal Data System: USRDS 1999 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases, 1999
2. U.S. Renal Data System: USRDS 2000 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
3. U.S. Renal Data System: USRDS 1998 Animal Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases, 1998
4. Koechler JA, Abramowitz PW, Swim SE, Daniels CE: Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 46:729-732, 1989
5. Health Care Finance Administration: 1999 HCFA Statistics. Available at http://www.hcfa.sov/stats/hstats99/Blucov99.pdf, accessed December 4, 2000
6. Health Care Finance Administration: Medicare Enrollment Trends 1966-1999. Available at http://www.hcfa.gov/stats/enrltrnd.htm, accessed December 4, 2000
7. Manley HJ, Bailie GR, Grabe DW: National database information: utility for an individual hemodialysis center. Am J Health Syst Pharm 57:902-906, 2000
8. Grabe DW, Low CL, Bailie GR, Eigele G: Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 47:117-121, 1997
9. Kaplan B, Mason NA, Shimp LA, Ascione FJ: Chronic hemodialysis patients. Part I: characterization and drug-related problems. Ann Pharmacother 28:316-319, 1994
10. Kaplan B, Shimp LA, Mason NA, Ascione FJ: Chronic hemodialysis patients. Part II: reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother 28:320-324, 1994
11. Stoutakis VA, Acchiardo SR, Martinez DR, Lorisch D, Wood GC: Role-effectiveness of the pharmacist in the treatment of hemodialysis patients. Am J Hosp Pharm 35:62-65, 1978
12. Tang I, Vrahnos D, Hatoum H, Lau A: Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 15:459-464, 1993
13. Possidente CJ, Bailie GR, Hood VL: Disruptions in drug therapy in long-term dialysis patients who require hospitalizations. Am J Health Syst Pharm 56:1961-1964, 1999
14. Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, Wade WE, DiPiro JT: Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team. Am J Health Syst Pharm 57:1994-1996, 2000
15. Chisholm MA, Vollenweider LJ, Mulloy LL, Muralidharan J, Martin BC, DiPiro JT: Pharmaceutical care services reduce the cost of medications prescribed in renal transplant clinic patients [abstract]. Pharmacotherapy 20:1280, 2000
16. Strand LM, Morley PC, Cipolle RJ: Drug-related problems: their structure and function. Ann Pharmacother 24:1093-1097, 1990
17. Hepler CD, Strand LM: Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533-543, 1990
18. Bleyer AJ, Hylander B, Sudo H, Nomoto Y, de la Torre E, Chen RA, Burkart JM: An international study of patient compliance with hemodialysis. JAMA 281:1211-1213, 1999
19. Long JM, Kee CC, Graham MV, Saethang TB, Dames FD: Medication compliance and the older hemodialysis patient. ANNA J 25:43-49, 1998
20. Curtin RB, Svarstad BL, Keller TH: Hemodialysis patients' noncompliance with oral medications. ANNA J 26:307-316, 1999
21. Bander SJ, Walters BA: Hemodialysis morbidity and mortality: links to patient non-compliance. Curr Opin Nephrol Hypertens 7:649-653, 1998
22. Leggat JE, Orzol SM, Hulbert-Shearon TE, et al.: Non-compliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis 32:139-145, 1998
23. Hospitalization in the United States, 1997. HCUP Fact Book no. 1. Available at http://www.ahcpr.gov/data/hcup/factbk1, accessed December 4, 2000
24. Nelson KM, Talbert RL: Drug-related hospital admissions. Pharmacotherapy 16:701-707, 1996
25. Britton ML, Lurvey PL: Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm 48:265-270, 1991
26. Bootman JL, Harrison DL, Cox E: The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 157:2089-2096, 1997